1. Home
  2. ACHV vs FTHY Comparison

ACHV vs FTHY Comparison

Compare ACHV & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.59

Market Cap

618.0M

Sector

Health Care

ML Signal

N/A

Logo First Trust High Yield Opportunities 2027 Term Fund

FTHY

First Trust High Yield Opportunities 2027 Term Fund

HOLD

Current Price

$13.47

Market Cap

494.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
FTHY
Founded
N/A
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.0M
494.6M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
ACHV
FTHY
Price
$7.59
$13.47
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.1M
90.9K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
10.93%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$13.20
52 Week High
$7.34
$14.84

Technical Indicators

Market Signals
Indicator
ACHV
FTHY
Relative Strength Index (RSI) 73.79 43.11
Support Level $4.04 $13.40
Resistance Level N/A $13.75
Average True Range (ATR) 0.33 0.11
MACD 0.08 -0.01
Stochastic Oscillator 98.71 24.77

Price Performance

Historical Comparison
ACHV
FTHY

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.

Share on Social Networks: